KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 0.05%.

  • Bristol Myers Squibb's Return on Invested Capital rose 3100.0% to 0.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.05% for FY2025, which is 2600.0% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Return on Invested Capital stood at 0.05%, which was up 3100.0% from 0.07% recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Invested Capital peaked at 0.02% during Q1 2023, and registered a low of 0.36% during Q4 2024.
  • For the 5-year period, Bristol Myers Squibb's Return on Invested Capital averaged around 0.12%, with its median value being 0.06% (2025).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -3300bps in 2024, then skyrocketed by 3100bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Invested Capital (Quarter) stood at 0.02% in 2021, then plummeted by -37bps to 0.03% in 2022, then decreased by -11bps to 0.03% in 2023, then tumbled by -1167bps to 0.36% in 2024, then skyrocketed by 85bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q4 2025, 0.07% for Q3 2025, and 0.09% during Q2 2025.